AveXis
Specializing in groundbreaking gene therapies for rare neurological genetic diseases, impacting lives profoundly.
est. 2013
Noema Pharma
A clinical-stage biotech pioneering a portfolio of disease-transforming therapeutics for CNS-mediated conditions
33 employees · est. 2019 · Basel, Switzerland
AveXis is the older company (2013 vs 2019).
Side-by-Side Comparison
| Metric | AveXis | Noema Pharma |
|---|---|---|
| Founded | ||
| Founded | 2013 older | 2019 |
| Headquarters | ||
| Headquarters | Not tracked yet | Basel, Switzerland |
| Employees | ||
| Employees | Not tracked yet | 33 |
| Industry | ||
| Industry | Biotechnology, Health Care | Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Grant | Series B |
| Total Funding | ||
| Total Funding | $75.10M | $184.00M |
| Funding Rounds | ||
| Funding Rounds | 5 | 3 |
| Services | ||
| Services | Not tracked yet | Development of oral small molecule therapeutics, Advancement of clinical-stage programs, Strategic collaborations with investors and partners, Educational resource provision for patients |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with neurological disorders, Individuals experiencing menopause-related symptoms, Healthcare providers, Investors interested in biotech and pharmaceutical innovations |
| Taxonomy | ||
| Taxonomy | Gene Therapy, Neurological Genetic Diseases, Rare Diseases, Medical Innovation, Novartis, Acquisition, Life-Threatening Conditions, Research & Development, Therapeutic Innovations | Biotech, Clinical-stage, Therapeutics Development, CNS-mediated Conditions, Orphan Brain Disorders, Neurological Diseases, Patient-centered Research, Novel Therapies, Symptom Management, R&D |
| Website | ||
| Website | avexis.com | noemapharma.com |
About AveXis
AveXis is a biotechnology startup specializing in groundbreaking gene therapies for rare neurological genetic diseases, impacting lives profoundly. Founded in 2013, the company was later acquired by Novartis on May 14, 2018, and adopted the name Novartis Gene Therapies in 2020. AveXis focuses on dev...
About Noema Pharma
Noema Pharma, founded in 2019, is a promising clinical-stage biotech company headquartered in Switzerland. The company’s mission is captured in its slogan: "A clinical-stage biotech pioneering a portfolio of disease-transforming therapeutics for CNS-mediated conditions." They are on the frontier of...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at AveXis and Noema Pharma — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at AveXis and Noema Pharma — by email.
Frequently Asked Questions
Compare AveXis with someone else
Start typing a company name or domain.